MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001)

被引：0

作者：

Gupta, Shilpa

Ballman, Karla V.

Galsky, Matt D.

Morris, Michael J.

Chen, Ronald C.

Chan, Timothy A.

Dercle, Laurent

Wen, Yujia

Sridhar, Srikala S.

Yen, Aihua Edward

Grivas, Petros

Tan, Alan

Baghaie, Shiva

Rosenberg, Jonathan E.

机构：

[1] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA

[2] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA

[3] Tisch Canc Inst, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, New York, NY USA

[5] Univ Kansas, Kansas City, KS USA

[6] Mem Sloan Kettering Canc Ctr, New York, NY USA

[7] Columbia Univ, New York Presbyterian Hosp, Dept Radiol, Med Ctr, New York, NY USA

[8] Univ Chicago, Chicago, IL USA

[9] Princess Margaret Canc Ctr, Canc Clin Res Unit, Toronto, ON, Canada

[10] Baylor Coll Med, Houston, TX USA

[11] Univ Washington, Seattle, WA USA

[12] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[13] Premier Onc Hem Assoc, Chicago, IL USA

[14] Alliance Clin Trials Oncol, Chicago, IL USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

基金：

美国国家卫生研究院;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS4607

引用

页数：1

共 50 条

[41] A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape
Gong, Jun
Reimers, Melissa A.
ADVANCES IN THERAPY, 2024, 41 (09) : 3441 - 3451
[42] CheckMate 331: An open-label, randomized phase III trial of nivolumab versus chemotherapy in patients (pts) with relapsed small cell lung cancer (SCLC) after first-line platinum-based chemotherapy (PT-DC).
Horn, Leora
Reck, Martin
Gettinger, Scott N.
Spigel, David R.
Antonia, Scott Joseph
Rupnow, Brent A.
Pieters, Anne
Selvaggi, Giovanni
Fairchild, Justin P.
Peters, Solange
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[43] Activity and tolerability of maintenance avelumab (AVE) immunotherapy after first-line platinum-based polychemotherapy in patients (pts) with locally advanced or metastatic squamous cell penile carcinoma: Initial results of PULSE study.
Thiery-Vuillemin, Antoine
Tartas, Sophie
Mourey, Loic
Colomba, Emeline
Borchiellini, Delphine
Goujon, Morgan
Lefort, Felix
Topart, Delphine
Barthelemy, Philippe
Lauridant, Geraldine
Meurisse, Aurelia
Vernerey, Dewi
Massard, Vincent
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[44] The RISC nomogram (RN) to predict overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (mUC) receiving first-line platinum-based combination chemotherapy (CT).
Necchi, Andrea
Sonpavde, Guru
Lo Vullo, Salvatore
Bamias, Aristotelis
Crabb, Simon J.
Harshman, Lauren Christine
Bellmunt, Joaquim
De Giorgi, Ugo
Sternberg, Cora N.
Ladoire, Sylvain
Wong, Yu-Ning
Yu, Evan Y.
Chowdhury, Simon
Niegisch, Guenter
Srinivas, Sandy
Vaishampayan, Ulka N.
Pal, Sumanta K.
Rosenberg, Jonathan E.
Galsky, Matt D.
Mariani, Luigi
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[45] A phase 3, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy.
Ciardiello, Fortunato
Bang, Yung-Jue
Bendell, Johanna C.
Cervantes, Andres
Brachmann, Rainer Karl
Zhang, Yuting
Raponi, Mitch
Farin, Heinrich
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[46] RANDOMIZED PHASE II STUDY OF BELOTECAN OR TOPOTECAN CHEMOTHERAPY AS SECOND-LINE CHEMOTHERAPY AFTER PLATINUM-BASED FIRST-LINE CHEMOTHERAPY FOR SMALL CELL LUNG CANCER
Yoon, S.
Lee, D. H.
Choi, C.
Lee, J. C.
Lee, J. S.
Kim, S.
ANNALS OF ONCOLOGY, 2014, 25
[47] First-line Therapy for locally advanced or metastatic Urothelial Carcinoma A randomized, controlled Phase-III-Trial comparing Pembrolizumab with or without platinum-based Combination Chemotherapy and Chemotherapy only in Patients with advanced or metastatic Urothelial Carcinoma (Keynote-361-AB 54/16 of the AUO)
Rexer, H.
Ohlmann, C. -H.
Retz, M.
UROLOGE, 2017, 56 (05): : 659 - 661
[48] Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
Ramalingam, Suresh S.
Novello, Silvia
Guclu, Salih Zeki
Bentsion, Dmitry
Zvirbule, Zanete
Szilasi, Maria
Bernabe, Reyes
Syrigos, Konstantinos
Byers, Lauren Averett
Clingan, Philip
Bar, Jair
Vokes, Everett E.
Govindan, Ramaswamy
Dunbar, Martin
Ansell, Peter
He, Lei
Huang, Xin
Sehgal, Vasudha
Glasgow, Jaimee
Bach, Bruce A.
Mazieres, Julien
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (32) : 3633 - +
[49] Phase II clinical trial of PM00104 (Zalypsis®) in urothelial carcinoma patients progressing after first-line platinum-based regimen
Castellano, Daniel E.
Bellmunt, Joaquim
Pablo Maroto, Jose
Font-Pous, Albert
Morales-Barrera, Rafael
Ghanem, Ismael
Suarez, Cristina
Martin Lorente, Cristina
Etxaniz, Olatz
Capdevila, Laia
Coronado, Cinthya
Alfaro, Vicente
Siguero, Mariano
Fernandez-Teruel, Carlos
Carles, Joan
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 857 - 867
[50] Phase II clinical trial of PM00104 (Zalypsis®) in urothelial carcinoma patients progressing after first-line platinum-based regimen
Daniel E. Castellano
Joaquim Bellmunt
José Pablo Maroto
Albert Font-Pous
Rafael Morales-Barrera
Ismael Ghanem
Cristina Suarez
Cristina Martín Lorente
Olatz Etxaniz
Laia Capdevila
Cinthya Coronado
Vicente Alfaro
Mariano Siguero
Carlos Fernández-Teruel
Joan Carles
Cancer Chemotherapy and Pharmacology, 2014, 73 : 857 - 867

← 1 2 3 4 5 →